Trulieve Form 3: CFO Reese Jan Reports No Beneficial Ownership

Reese Jan, identified as Chief Financial Officer and a director of Trulieve Cannabis Corp. (TRUL), filed an Initial Statement of Beneficial Ownership on Form 3 reporting no ownership of the issuer's common stock as of the 09/08/2025 event date.

Rhea-AI Filing Summary

Reese Jan, identified as Chief Financial Officer and a director of Trulieve Cannabis Corp. (TRUL), filed an Initial Statement of Beneficial Ownership on Form 3 reporting no ownership of the issuer's common stock as of the 09/08/2025 event date. The filing references an Exhibit 24 Power of Attorney and is signed on behalf of the reporting person by Eric Powers as attorney-in-fact on 09/30/2025.

Insights

Securities Compliance Analyst

TL;DR: Officer filed a Form 3 and reported zero direct ownership of company securities.

The Form 3 is routine: it identifies the reporting person as Chief Financial Officer and director, shows the event date of 09/08/2025, and explicitly reports no non-derivative or derivative securities beneficially owned. Inclusion of Exhibit 24 indicates an executed power of attorney used to sign the filing. From a compliance perspective this satisfies the initial disclosure requirement under Section 16 for an officer/director, but it conveys no ownership stakes to analyze for insider transactions.

Corporate Governance Specialist

TL;DR: Governance disclosure completed; absence of reported holdings means no insider position disclosed.

The document documents the reporting relationship and the lack of beneficial ownership. The filing being signed by an attorney-in-fact is standard practice when authorized. There are no derivative positions, amendments, or additional notes that indicate material governance events. This is a neutral governance disclosure with no immediate impact on shareholder control or dilution.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Reese Jan

Role Chief Financial Officer

Type	Security	Shares	Price	Value
holding	None	--	--	--

Holdings After Transaction: None — 0 shares (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Reese Jan report on the Form 3 for Trulieve (TCNNF)?

The Form 3 reports that Reese Jan, Chief Financial Officer and director, beneficially owns no non-derivative or derivative securities as of the 09/08/2025 event date.

When is the event date reported on the Form 3?

The event date listed on the Form 3 is 09/08/2025.

Was the Form 3 signed and by whom?

Yes. The filing is signed on behalf of the reporting person by Eric Powers, as Attorney-in-Fact, with a signature date of 09/30/2025.

Does the Form 3 show any derivative securities or options for Reese Jan?

No. Table II lists no derivative securities; the filing shows none and zero amounts reported.

Is there an exhibit attached to the filing?

Yes. The filing references Exhibit 24, a Power of Attorney filed with the Form 3.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 09/30/2025 - 10:21 AM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Reese Jan

(Last) (First) (Middle)

C/O TRULIEVE CANNABIS CORP.

6749 BEN BOSTIC ROAD

(Street)

QUINCY FL 32351

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
09/08/2025

3. Issuer Name and Ticker or Trading Symbol
Trulieve Cannabis Corp. [ TRUL ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
None	0	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24 Power of Attorney filed herewith.

	/s/ Eric Powers, as Attorney-in-Fact	09/30/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.